ViennaLab Diagnostics

ViennaLab Diagnostics

Vienna, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ViennaLab Diagnostics is a private, revenue-generating company that develops and distributes molecular diagnostic assays through an international network. Its core technology platforms include StripAssays®, RealFast™ assays, and NGS assays, offering solutions ranging from simple single-marker detection to complex genetic analysis. As part of the BioVendor Group, it leverages broader R&D and distribution capabilities while maintaining a focus on user-friendly, regulated IVD products for clinical laboratories. The company operates in the growing markets of personalized medicine and genetic testing.

OncologyGenetic DisordersOther

Technology Platform

Three core platforms: 1) StripAssays® (membrane-based array for simple, multi-variant detection), 2) RealFast™ assays (real-time PCR for targeted, quantitative analysis), and 3) NGS assays (next-generation sequencing for complex genomic profiling).

Opportunities

The growing adoption of pharmacogenetics in routine clinical practice and the expansion of comprehensive cancer genomic profiling present significant market opportunities.
Furthermore, the EU's IVDR regulation creates a barrier to entry that could benefit established, compliant players like ViennaLab.

Risk Factors

The primary risk is the failure to successfully transition its product portfolio to the new EU IVDR certification, which would prohibit sales in key markets.
Intense competition from large diagnostics corporations and rapid technological obsolescence also pose significant threats.

Competitive Landscape

ViennaLab competes in the crowded molecular diagnostics market against global giants (e.g., Roche, Qiagen, Thermo Fisher) and numerous specialized firms. Its differentiation lies in a focus on user-friendly, CE/IVD assays across multiple technology platforms and its distribution reach as part of the BioVendor Group.